BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rivero-Hinojosa S, Grant M, Panigrahi A, Zhang H, Caisova V, Bollard CM, Rood BR. Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. Nat Commun 2021;12:6689. [PMID: 34795224 DOI: 10.1038/s41467-021-26936-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz Cuevas MV, Hardy M, Larouche J, Apavaloaei A, Kina E, Vincent K, Gendron P, Laverdure J, Durette C, Thibault P, Lemieux S, Perreault C, Ehx G. BamQuery: a proteogenomic tool for the genome-wide exploration of the immunopeptidome.. [DOI: 10.1101/2022.10.07.510944] [Reference Citation Analysis]
2 Xiang H, Zhang L, Bu F, Guan X, Chen L, Zhang H, Zhao Y, Chen H, Zhang W, Li Y, Lee LJ, Mei Z, Rao Y, Gu Y, Hou Y, Mu F, Dong X. A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources. Cancers (Basel) 2022;14:3016. [PMID: 35740681 DOI: 10.3390/cancers14123016] [Reference Citation Analysis]
3 Levitsky LI, Kuznetsova KG, Kliuchnikova AA, Ilina IY, Goncharov AO, Lobas AA, Ivanov MV, Lazarev VN, Ziganshin RH, Gorshkov MV, Moshkovskii SA. Validating Amino Acid Variants in Proteogenomics Using Sequence Coverage by Multiple Reads. J Proteome Res 2022. [PMID: 35536917 DOI: 10.1021/acs.jproteome.2c00033] [Reference Citation Analysis]
4 Venkataramany AS, Schieffer KM, Lee K, Cottrell CE, Wang PY, Mardis ER, Cripe TP, Chandler DS. Alternative RNA Splicing Defects in Pediatric Cancers: New Insights in Tumorigenesis and Potential Therapeutic Vulnerabilities. Ann Oncol 2022:S0923-7534(22)00390-8. [PMID: 35339647 DOI: 10.1016/j.annonc.2022.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Pitolli C, Marini A, Sette C, Pagliarini V. Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer. IJMS 2022;23:2811. [DOI: 10.3390/ijms23052811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xiao P, Li Y, Wang D. Amplifying antitumor T cell immunity with versatile drug delivery systems for personalized cancer immunotherapy. Medicine in Drug Discovery 2022;13:100116. [DOI: 10.1016/j.medidd.2021.100116] [Reference Citation Analysis]
7 Levitsky L, Kuznetsova K, Kliuchnikova A, Ilina I, Goncharov A, Lobas A, Ivanov M, Lazarev V, Ziganshin R, Gorshkov M, Moshkovskii S. Validating amino acid variants in proteogenomics using sequence coverage by multiple reads.. [DOI: 10.1101/2022.01.08.475497] [Reference Citation Analysis]
8 Nony E, Moingeon P. Proteomics in support of immunotherapy: contribution to model-based precision medicine. Expert Rev Proteomics 2021;:1-10. [PMID: 34937491 DOI: 10.1080/14789450.2021.2020653] [Reference Citation Analysis]